Related Experiment Videos
Trisomy 13 and myelodysplastic syndrome
G C Beverstock1, J E Ploem, H Wessels
1Department of Human Genetics, State University Hospital, Leiden, The Netherlands.
Cancer Genetics and Cytogenetics
|September 1, 1990
Summary
This study presents a rare case of myelodysplastic syndrome-refractory anemia with excess blasts (MDS-RAEB) with trisomy 13 as the only genetic abnormality. The findings highlight a unique cytogenetic profile in MDS-RAEB.
Area of Science:
- Hematology
- Cytogenetics
- Oncology
Background:
- Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
- Refractory anemia with excess blasts (RAEB) is a subtype of MDS characterized by specific blast counts.
- Cytogenetic abnormalities are common in MDS and influence prognosis.
Observation:
- A rare case of MDS-RAEB with trisomy 13 as the sole chromosomal abnormality is reported.
- This represents the second documented instance of this specific genetic finding in MDS-RAEB.
- Trisomy 13 was confirmed using in situ hybridization with a centromere-specific probe.
Findings:
- The patient's MDS-RAEB exhibited trisomy 13 as the exclusive cytogenetic abnormality.
- The diagnostic confirmation utilized an alphoid repeat probe (L1.26) specific for chromosome 13 centromeres.
- This case adds to the limited understanding of trisomy 13's role in MDS pathogenesis.
Implications:
- This case expands the known spectrum of cytogenetic abnormalities in MDS-RAEB.
- Further research is warranted to understand the clinical significance and prognostic impact of trisomy 13 in MDS.
- The findings may contribute to refining diagnostic and therapeutic strategies for MDS patients with rare chromosomal aberrations.